After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Ionis Pharmaceuticals Inc is $6.68B. A total of 1.8 million shares were traded on the day, compared to an average of 1.69M shares.
In the most recent transaction, Monia Brett P sold 1,160 shares of IONS for 41.74 per share on Jul 11 ’25. After the transaction, the Chief Executive Officer now owns 179,820 company shares. In a previous transaction on May 01 ’25, Hayden Michael R bought 15,000 shares at 31.86 per share. IONS shares that Director owns now total 50,219.
Among the insiders who sold shares, Birchler Brian disposed of 680 shares on Apr 16 ’25 at a per-share price of $28.37. This resulted in the EVP, Corp and Development Ops holding 56,660 shares of IONS after the transaction. In another insider transaction, Jenne Kyle sold 3,016 shares at $28.36 per share on Apr 16 ’25. Company shares held by the EVP, Chf GL Pdt Str Ofcr now total 11,199.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, IONS has a high of $52.34 and a low of $23.95.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IONS’s latest balance sheet shows that the firm has $2.11B in Cash & Short Term Investments as of fiscal 2021. There were $1.25B in debt and $240.55M in liabilities at the time. Its Book Value Per Share was $2.99, while its Total Shareholder’s Equity was $771.74M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IONS is Buy with a score of 4.22.
